stoxline Quote Chart Rank Option Currency Glossary
  
Viveon Health Acquisition Corp. (VHAQ)
10  0 (0%)    04-19 10:21
Open: 10
High: 10
Volume: 434
  
Pre. Close: 10
Low: 10
Market Cap: 66(M)
Technical analysis
2024-04-26 4:45:40 PM
Short term     
Mid term     
Targets 6-month :  11.68 1-year :  13.64
Resists First :  10 Second :  11.68
Pivot price 0.66
Supports First :  3.82 Second :  0
MAs MA(5) :  2 MA(20) :  0.5
MA(100) :  8.13 MA(250) :  9.94
MACD MACD :  -0.4 Signal :  -1.4
%K %D K(14,3) :  33.3 D(3) :  11.1
RSI RSI(14): 87.5
52-week High :  12.47 Low :  0
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ VHAQ ] has closed above the upper band by 43.5%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 251.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 10.01 - 10.05 10.05 - 10.09
Low: 9.9 - 9.94 9.94 - 9.99
Close: 9.93 - 10 10 - 10.07
Company Description

Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Norcross, Georgia.

Headline News

Fri, 19 Jan 2024
Lucid Diagnostics - EsoGuard ® Esophageal DNA Test - Health Professional Radio

Wed, 12 Apr 2023
(Updated) Clearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate ... - GlobeNewswire

Mon, 10 Apr 2023
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech - Longevity.Technology

Mon, 06 Feb 2023
SPAC Viveon terminates planned merger with Suneva Medical - Seeking Alpha

Tue, 13 Sep 2022
Suneva Medical Launches 30 mL PRP Gel Tubes of Amplifine, Allowing for More Variety and Efficiency in PRP ... - PR Newswire

Fri, 29 Apr 2022
Viveon Health Acquisition Corp. Received Audit Opinion with Going Concern Explanation - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
AMEX
Sector:
Financial Services
Industry:
Shell Companies
Shares Out 7 (M)
Shares Float 1 (M)
Held by Insiders 75.2 (%)
Held by Institutions 33.2 (%)
Shares Short 2 (K)
Shares Short P.Month 1 (K)
Stock Financials
EPS -0.04
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -2.34
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -1.2 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow -2 (M)
Levered Free Cash Flow 35 (M)
Stock Valuations
PE Ratio -250
PEG Ratio 0
Price to Book value -4.28
Price to Sales 0
Price to Cash Flow -38
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android